CSC, an adenosine A2A receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats-Reference-Cited by-同舟云学术

CSC, an adenosine A2A receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats

Published:2008-01 Issue: Volume:1191 Page:192-199
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Aguiar Lissiana M.V.,Macêdo Danielle S.,Vasconcelos Silvania M.M.,Oliveira Aline A.,de Sousa F. Cléa F.,Viana Glauce S.B.

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference43 articles.

1. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats;Aguiar;Pharmacol. Biochem. Behav.,2006

2. Adenosine A2A receptor antagonist treatment of Parkinson's disease;Bara-Jimenez;Neurology,2003

3. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease;Bibbiani;Exp. Neurol.,2003

4. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats;Bové;Synapse,2002

5. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias;Callon;Brain,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds;Expert Opinion on Drug Discovery;2023-06-23

2. A2A adenosine receptor agonists, antagonists, inverse agonists and partial agonists;International Review of Neurobiology;2023

3. Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies;Cephalalgia;2022-03-18

4. Evaluation of efficiency omega 3 fatty acid improves the behavioural phenotype and protects against oxidative stress against MPP⁺ induces Parkinson's disease in mice;pakistan journal of pharmaceutical sciences;2021-05-01

5. Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease;International Journal of Molecular Sciences;2020-07-04